Skip to content
Home/Companies/Healthcare/PharmaReview
PH

PharmaReview

Healthcare·UK·Active·5yr hold

PharmaReview is a healthcare company, headquartered in UK.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns PharmaReview?

PharmaReview is currently owned by Bridgepoint through Growth II (BG II) (2024 vintage), since 2021.

Hand-verified · 3 sources · updated 2026-04-21

Bridgepoint
Investor
Bridgepoint
Growth II (BG II) · 2024 · Growth

Key facts

HQUK
SectorHealthcare

More from Growth II (BG II)

Other portfolio companies in the same fund.

Exile Group
Active
Business ServicesUK· 2026
Chime Software
Active
TMTUK· 2025
Zuto
Active
FinancialsUK· 2025
Condatis
Active
TMTUK· 2024
Identicare
Active
HealthcareUK· 2024
Surikat
Active
TMTSweden· 2024

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abcam (exited)
Active
EMV CapitalUK
Data refreshed weekly · Sourced from public filings